Easy-to-swallow Zantac
This article was originally published in The Tan Sheet
Executive Summary
Glaxo's NDA for 150 and 300 mg doses of the prescription anti- ulcer drug Zantac in GELdose capsules is deemed "approvable" by FDA on April 30. Glaxo said that the GELdose capsules are "easier for some people to swallow." Zantac has been touted as a possible Rx-to-OTC switch candidate; however, the Glaxo product lags behind other H[2] antagonist switches at FDA.